Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Cash from Financing Activities
Amedisys Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Cash from Financing Activities
-$87.5m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-5%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
$2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Amedisys Inc's Cash from Financing Activities?
Cash from Financing Activities
-87.5m
USD
Based on the financial report for Dec 31, 2023, Amedisys Inc's Cash from Financing Activities amounts to -87.5m USD.
What is Amedisys Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-5%
Over the last year, the Cash from Financing Activities growth was -188%. The average annual Cash from Financing Activities growth rates for Amedisys Inc have been -80% over the past three years , 20% over the past five years , and -5% over the past ten years .